Skip to main content

MoneyWorks4Me

Solara Active Pharma Sciences informs about disclosure

11 Jun 2024 Evaluate

Solara Active Pharma Sciences has informed that the exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June 10, 2024 for SRJR Enterprise LLP & PACs.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1823.30
Dr. Reddys Labs. 1376.55
Cipla 1403.70
Lupin 1983.00
Zydus Lifesciences 1193.00
View more..